Claro Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $851K | Buy |
9,286
+824
| +10% | +$72.1K | 0.09% | 187 |
|
|
2026
Q1 | $721K | Sell |
8,462
-1,454
| -15% | -$130K | 0.09% | 183 |
|
|
2025
Q4 | $784K | Buy |
9,916
+259
| +3% | +$20.3K | 0.11% | 169 |
|
|
2025
Q3 | $772K | Sell |
9,657
-415
| -4% | -$35.4K | 0.11% | 160 |
|
|
2025
Q2 | $916K | Sell |
10,072
-7,578
| -43% | -$692K | 0.15% | 129 |
|
|
2025
Q1 | $1.65M | Sell |
17,650
-604
| -3% | -$54.1K | 0.22% | 83 |
|
|
2024
Q4 | $1.66M | Sell |
18,254
-3,926
| -18% | -$375K | 0.22% | 85 |
|
|
2024
Q3 | $2.3M | Buy |
22,180
+1,364
| +7% | +$139K | 0.3% | 63 |
|
|
2024
Q2 | $2.02M | Buy |
20,816
+482
| +2% | +$44.5K | 0.32% | 58 |
|
|
2024
Q1 | $1.83M | Buy |
20,334
+697
| +4% | +$59.1K | 0.32% | 57 |
|
|
2023
Q4 | $1.57M | Sell |
19,637
-473
| -2% | -$35.6K | 0.34% | 61 |
|
|
2023
Q3 | $1.43M | Buy |
20,110
+2,672
| +15% | +$200K | 0.36% | 61 |
|
|
2023
Q2 | $1.34M | Buy |
17,438
+683
| +4% | +$52.9K | 0.33% | 65 |
|
|
2023
Q1 | $1.26M | Buy |
16,755
+515
| +3% | +$38.3K | 0.37% | 63 |
|
|
2022
Q4 | $1.28M | Sell |
16,240
-245
| -1% | -$18.4K | 0.42% | 57 |
|
|
2022
Q3 | $1.32M | Hold |
16,485
| – | – | 0.53% | 42 |
|
|
2022
Q2 | $1.32M | Buy |
16,485
+3,556
| +28% | +$278K | 0.53% | 42 |
|
|
2022
Q1 | $1.1M | Hold |
12,929
| – | – | 0.4% | 61 |
|
|
2021
Q4 | $1.1M | Buy |
12,929
+164
| +1% | +$12.8K | 0.4% | 61 |
|
|
2021
Q3 | $965K | Buy |
12,765
+1,908
| +18% | +$152K | 0.41% | 61 |
|
|
2021
Q2 | $883K | Buy |
10,857
+173
| +2% | +$14.1K | 0.4% | 58 |
|
|
2021
Q1 | $842K | Buy |
10,684
+257
| +2% | +$20.1K | 0.43% | 61 |
|
|
2020
Q4 | $892K | Sell |
10,427
-325
| -3% | -$26.9K | 0.47% | 57 |
|
|
2020
Q3 | $830K | Sell |
10,752
-63
| -0.6% | -$4.8K | 0.53% | 46 |
|
|
2020
Q2 | $792K | Sell |
10,815
-84
| -0.8% | -$5.97K | 0.55% | 48 |
|
|
2020
Q1 | $723K | Buy |
10,899
+142
| +1% | +$10K | 0.67% | 36 |
|
|
2019
Q4 | $741K | Buy |
10,757
+94
| +0.9% | +$6.41K | 0.57% | 47 |
|
|
2019
Q3 | $784K | Buy |
10,663
+230
| +2% | +$16.7K | 0.7% | 40 |
|
|
2019
Q2 | $748K | Buy |
10,433
+1,324
| +15% | +$94K | 0.69% | 41 |
|
|
2019
Q1 | $624K | Sell |
9,109
-27
| -0.3% | -$1.74K | 0.62% | 48 |
|
|
2018
Q4 | $612K | Buy |
+9,136
| New | +$572K | 0.49% | 43 |
|
Other funds holding CL
Claro Advisors's CL Position: Q2 2026 in Review
Claro Advisors increased its Colgate-Palmolive (CL) stake by 9.7% in Q2 2026, buying an estimated $72.1K and bringing the position to 9,286 shares worth $851K. The position accounts for 0.09% of the portfolio, ranked #187.
Claro Advisors first reported a position in CL in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.3M in Q3 2024. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Claro Advisors held 9,286 shares of Colgate-Palmolive worth $851K as of Q2 2026.
- Claro Advisors bought 824 Colgate-Palmolive shares in Q2 2026, an estimated $72.1K.
- Colgate-Palmolive made up 0.09% of Claro Advisors's portfolio in Q2 2026, its #187 holding.
- Claro Advisors first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 31 quarters since.
- Claro Advisors's Colgate-Palmolive position peaked at $2.3M in Q3 2024.
- 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.